跳至主要内容
临床试验/IRCT138706061113N1
IRCT138706061113N1已完成未知

The effect of omega3 supplementation in preeclampsia in pregnant women at risk in Qazvin

Qazvin University of Medical Sciences, Zahravi drug company0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

Background :Identification of factors preventing from preeclampsia in high risk pregnant women is a significant importance.Omega-3 supplementation may reduce the risk of preeclampsia.
Objective : In this research was assessed the effects of Omega-3 supplementation,on high risk pregnancy for preeclampsia in Qazvin city.
Methods:This single-blind randomized clinical trial was conducted in Qazvin city. The sample was 100 high risk pregnant women for preeclampsia(between 14-18weeks of gestation). 50were assigned to Omega-3 group and 50 to the placebo group.Women were assigned to daily supplementation with 1000mg omega-3 or placebo until delivery.Then preeclampsia and pregnancy outcome's were assessed in two groups.After employing data were recoeded and analyzed statistically using t-test,X2,mannwhitney and fisher exact test.
findings :There were significant differences between the Omega-3 and Placebo groups in the rate(p=0.015) and intensity(P=0.01) of preeclampsia.The correlation was found between the Omega-3 group and outcome of pregnancy (birth weight and Apgar score)( P=0.000,p=0.002).
Conclusion :Our results suggest that supplementation with Omega-3 during pregnancy reduced the risk of preeclampsia in high risk pregnant womenThus it seems necessary to promot educational nutritiant programs for pregnant women .
Keywords : high risk pregnancy,preeclampsia,fatty acids with long chins of omega3

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 45 years(—)
性别
Female

入选标准

  • pregnant women whose gestational age is between 14 to 18 weeks and are ready to cooperate, being high risk for preeclampsia (first gravidy, under the age of 20 and over 40, a history of preeclampsia during the previous gravidy or immediate member of family, BMI more than 29, history of twin fetuses);
  • consumption of Aspirin, Calcium, anticoagulants, allergy to omega3 or fish, presence digestive diseases which need to treatment,

排除标准

  • 未提供

研究者

发起方
Qazvin University of Medical Sciences, Zahravi drug company

相似试验